|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's range||84.74 - 87.32|
|52-week range||81.37 - 233.14|
|Beta (5Y monthly)||0.28|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||94.67|
NEW YORK, March 3, 2021 /CNW/ -- Pomerantz LLP is investigating claims on behalf of investors of Galapagos NV ("Galapagos" or the "Company") (NASDAQ: GLPG). Such investors are advised to contact Robert S.
Despite some serious setbacks, this beaten-down biotech could be a terrific bargain at recent prices.
GLPG earnings call for the period ending December 31, 2020.